Loading

Journal of Family Medicine and Community Health

Many Developmental Errors and or Pathological Conditions May Be Associated with Marker Dots or Small Supernumerary Chromosomes

Review Article | Open Access | Volume 7 | Issue 1

  • 1. Retired Professor, Department of Genetics, 24, Kaushalnagar, P.O. Misrod, Bhopal (MP), 462047, India
+ Show More - Show Less
Corresponding Authors
Hit Kishore Goswami, Retired Professor, Department of Genetics, 24, Kaushalnagar, P.O. Misrod, Bhopal (MP), 462047, India, Tel: 91-9425371765.
Abstract

In the modern context, chromosomes should be defined as “compound unit of inheritance loaded with sequences of nucleic acids following intracellular molecular events of transmission and cell division”. The definition is based on observations which must differentiate between the specific chromosome structure and the chromatin structures expelled by chromosomes. During 1960s and 1970s, small chromatin dots were seen in addition to the normal chromosomal component among many metaphases prepared from tissues of brain tumours by various workers but the fact that certain specific chromosomes, under a triggered molecular mechanism, expel chromatin dots was realized as an important event by the present author in 1986. After observing clear pictures of various metaphases and identifying the specific chromosomes by G banding showing emanating chromatin dots, we had named these small chromosome structures as “Marker Dots” (MDs). These marker dots were repeatedly observed and defined (1986,1992) as being detached from a specific chromosome; sometimes also demonstrated as held or attached with a fine fibril to the chromosome. Lately, these expelled chromosome structures have been named as small Supernumerary Marker Chromosomes (SMCs) by various workers and with the help of most modern techniques like DNA hybridisation in situ, FISH techniques they have also reported exactly same results that chromatin structures are expelled from specific chromosomes. Since neither small marker chromosomes (SMCs) nor marker dots (MDs), though, both have been shown to be produced by any chromosome within a cell, have definite centromere, we can best designate them as marker dots. Our observations already published have exhibited marker dots to be found among some metaphases of normal persons without any phenotypic variable, sometimes in persons with malignant features or sometimes also associated with many pathological conditions as well as in recurrently aborting couples. Hence it would be logical to hypothesize that “Emanation of chromatin is an accelerated epigenetic molecular triggering within specific loci of chromosomes.” Influence or impact of this expelled chromatin structure might be related with the activated DNA sequences on the chromosome loci from where and which specific chromosome, this has been “expelled. Since the mode of origin as well as functional aspects of both Marker Dots and SMCs are identical; both are present in normal persons and sometimes affiliated with some and the other disease, these should be considered as synonyms. Both appear to be the same and can help in genetic counselling.

Keywords
  • Chromosome definition
  • Marker dots and small marker chromosomes
  • Marker chromatin bodies as indicators of chromosomal mutagenesis
  • Genetic counselling
  • Marker dots and SMCs as synonyms

 

Citation

Goswami HK (2020) Many Developmental Errors and or Pathological Conditions May Be Associated with Marker Dots /Small Supernumerary Chromosomes. J Family Med Community Health 7(1): 1169.

INTRODUCTION

A few chromatin dots of variable sizes were reported in cells of many brain tumour tissues [1-4]. Our studies by standard lymphocyte cultures and staining with Giemsa, G and C banding and Feulgen’s approaches on more than 600 persons revealed definite origin of these chromatin dots of variable sizes as the outcome of some triggered molecular mechanism operative on chromatin. We had published clear pictures of chromosomes, observed in many cases revealing direct detachment of these dots, termed as “Marker Dots (MDs). These emanating marker dots [5-11] varied in origin from different chromosomes (as identified by G banding) and were associated with many pathological features more commonly with malignancies and recurrent abortions. These expelled chromatin dots are being discovered by most modern molecular approaches including FISH and DNA hybridisation techniques by various workers and have been termed as small supernumerary marker chromosomes (SMCs). Nevertheless, Marker Dots or supernumerary marker chromosomes are those chromatin -structures which are expelled from a specific chromosome (s) as the consequence of “molecular triggering of the specific loci within a particular chromosome and any chromosome can be molecularly affected and involved in the process of chromatin attenuation [5,7,12- 16]. There are evidences published by very many workers [17- 23] that appearance of supernumerary marker chromosome is a definite denominator of chromosomal involvement representing onset of some or the other pathological condition. Similar to these small marker chromosomes we have described many years earlier [5,7] these larger dots as Marker Dots. Obviously, the nature of a pathological condition would depend mainly on the “genic” content of the Marker Dot / small Supernumerary marker chromosome and the site of chromatin attenuation at the chromosome from where the chromatin-log has been de-saddled (dislodged from or near centromere, telomere or any other site). This paper Obviously opines that marker dots and small marker chromosomes may be the same structures. Since marker dots have been seen and described as being detached from specific locus [5,6,12,13] as free dots in the vicinity or still attached with a fine stainable fibril, and several chromosomes have been reported to be involved, the “marker-dot emanation “should be listed as a definite kind of chromosomal aberration to be tagged with other standard aberrations (deletion, duplication, inversion and translocation). Formation or appearance of SMCs also is due to chromatin expelled from some or the other chromosome.

MATERIALS AND METHODS

Studies on genotoxic assessments by lymphocyte cultures on persons exposed to MIC gas as well as including various control subjects, family members of normal controls, patients with many syndromes and pathological conditions in and around Bhopal were studied over two decades. Comparative observations on more than 600 persons had established that chromosomal damages have been installed among seriously exposed persons. Studies have been based on standard protocols of cell cultures and chromosome studies with specific staining schedules [5,6,13- 15]. Staining schedules of simple G staining, G & C banding and Feulgen’s approach have been repeatedly carried out. Table 1 presents a list, though may be incomplete as there are many workers with similar results and the Table 2 presents our already published results.

Table 1: Association of Marker dots/Small supernumerary chromosomes with parental chromosome.

Authors Observation Comments
Cox et al., 1965; Lubs et al 1966; 
Dharker et al., 1973 a,b.
Goswami, 1986
Small Chromatin dots
Chromatin dots more than 1.5 to 2 mu were named as Marker dots
Chromatin bodies in malignant
Tumours of child hood / brain tumours
Observed in cells of methylcyanate exposed persons in Bhopal (after gas exposure in Dec -1984)
Goswami, 1993 , 2016, 2017a,b, 2018 
Goswami & Chang, 2001;
Goswami et al., 1990, 1992, 1997, 1998
Obo Chromosome SOME OR THE Other chromosomes numbers in involved to detected show detaching Mds 
1,2,3, 4,5, 6,7,8, 9,11, 16,17,19; 20, Y 
Observed attenuation of marker dots suggesting that marker dots are indicators of chromosomal mutagenesis. 
1. Pelvic lipomatosis with Renal ectopia
2. Gradual Disappearnce of right ulna in achild
3. Recurrently aborting mothers
4. Mentally retarded children
5. Toxic effects of methylisocyanate gas exposure among hundreds of affected persons
6. EVEN in 5% seemingly normal persons
7. Extremely important for GENETIC COUNSELLING for early detection of malignancy and or any embryological or developmental error (?).(Goswami & Chang,2001)
 

Pietrzak J , Mrasek K, Obersztyn E , Stankiewicz P, Kosyakova N, Weise A, Cheung S W, Cai W W , Eggeling F, Mazurczak T, Bocian E , Liehr T ( 2007)

Bae M H , Yoo HW , Lee JO, Maria Hong M and SeoEJ (2011)

Molecular cytogenetic characterization of eight small supernumerary marker chromosomes originating from chromosomes 2, 4, 8,18, and 21.

 

 

Case 1

Identified in three patients with dysmorphic features, psychomotor retardation and multiple congenital anomalies. We also attempted to correlate the patients’ genotypes with phenotypes

 

Analyzing SMCs using high-resolution chromosomal microarray can help identify specific gene contents and to offer proper genetic counseling by determining genotype-phenotype correlations

Huang,B , Pearle, P , Rauen KA ; ,Cotter P D. ( 2012) https://doi.org/10.1002/ ajmg.a.35385 -Chromosome 6-------
Clinical outcomes varied. The clinical manifestations observed in Case 1 included small for gestational age, feeding difficulty at birth, hydronephrosis, deviated septum and dysmorphic features, while the phenotype is apparently normal in Case 2. Array comparative genomic hybridization 
(CGH) was performed and showed increase in dosage for approximately 26 Mb of genetic material from the proximal short and long arms of chromosome 6 euchromatin. 
The difference in the clinical presentation in patients may have resulted from the difference in the actual gene contents of the marker chromosomes and/or the differential distribution of the mosaicism

Reddy et al., 2013

Chen et al., (2017) SMCs detected in routine chromosomal analysis, SMCs originating from chromosome 21

Dalpra et al., (2005)

 

Kurtas N E , Xumerle L , Leonardelli L, donne

SMCs Proved by genomic hybridization in a genome-wide analysis

SMCs derived from chromosome 21.

Extensive survey revealed that Acrocentric chromosomes also play definite role in generating SMCs.

Studied observations on movements of SMCs during regular cell divisions and found as laggards

A small supernumerary marker chromosome is often seen in patients with developmental disorders. Prior to array-based comparative genomic hybridization markers were rarely genotyped end to end. In this study, a valid genotype-to-phenotype correlation was possible because the supernumerary marker chromosomes were fully characterized by array-based comparative genomic hybridization in a genome-wide analysis

Prenatal diagnosis and molecular cytogenetic characterization of mosaicism for a small supernumerary marker chromosome derived from chromosome 21.

An Na, Y Yang, Xi Q, Yue F, Liu R, Li S, Wang R (2019) Molecular Characterization of Molecular Characterization of Mosaicism for a Small Supernumerary Marker

Chromosome Derived from Chromosome Y in an Infertile Male with Apparently Normal Phenotype: A Case Report and Literature Review

Studied Proved that Y chromosome is involved and indicated that SMC may be responsible in causing oligospermia A total of 113 of the 241 sSMCs were detected antenatally, and 128 were detected postnatally. There were 52 inherited and 172 de novo cases. Abnormal phenotype was present in 137 cases (57%), 38 of which were antenatally diagnosed. A mosaic condition was observed in 87 cases (36%).The chromosomes generating the sSMCs were acrocentric in 132 cases (69%) and non-acrocentric chromosomes in 60 cases (31%); a neocentromere was hypothesized in three cases involving chromosomes 6, 8, and 15 Authors have studied by a whole genomic approach and trios genotyping, 12 de novo, nonrecurrent small supernumerary marker chromosomes (sSMC), detected as mosaics during pre- or postnatal diagnosis and associated with increased maternal age. Findings strongly suggest that most sSMCs are the result of a multiple-step mechanism, initiated by maternal meiotic nondisjunction followed by postzygotic anaphase lagging of the supernumerary chromosome and its subsequent chromothripsis. Authors claim first report of the chromosomal Y anomalies, SRY gene translocated from der(Y) (pter ? q11.23) to qter of normal chromosome Y, were not reported before. Our findings indicated that the mosaic presence of sSMC(Y) may be the main cause of severe oligospermia although no other apparent abnormalities were observed. A total of

Figure 1 exhibits enhanced sister chromatid exchanges in a female patient exposed with toxic exposure to accidently released MIC gas in Bhopal during 1984.

A metaphase from lymphocytes of a female patient seriously affected with exposure of Methylisocyanate gas during December 1984  exhibiting chromosomal mutagenesis as evidenced by many Sister chromatid exchanges; note the release of chromatin material from many  chromosomes (arrowed and indicated with lines). The most significant part is that chromatin may be released as dots or linear structures which get  round up to form Marker Dot or SMC. This woman died of multiple diseases including dyspnoea and cancer cervix.

Figure 1 A metaphase from lymphocytes of a female patient seriously affected with exposure of Methylisocyanate gas during December 1984 exhibiting chromosomal mutagenesis as evidenced by many Sister chromatid exchanges; note the release of chromatin material from many chromosomes (arrowed and indicated with lines). The most significant part is that chromatin may be released as dots or linear structures which get round up to form Marker Dot or SMC. This woman died of multiple diseases including dyspnoea and cancer cervix.

Figure 2 presents comparative histogram of the origin and association of release of marker dots (MDs) among various categories of persons studied and relationship of Mds with kind of aberrations.

Based on computations of clear metaphases and counting of type of aberrations in each kind of patients and controls this figure displays a  comparative picture of distribution of Marker Dots (MDS) . In all categories of subjects/ persons studied the aberration -translocation appears to be  by and large more associated with “release of chromatin material”.

Figure 2 Based on computations of clear metaphases and counting of type of aberrations in each kind of patients and controls this figure displays a comparative picture of distribution of Marker Dots (MDS) . In all categories of subjects/ persons studied the aberration -translocation appears to be by and large more associated with “release of chromatin material”.

Observations

This was a remarkable find to record in slides from lymphocyte cultures of exposed persons and confirms the presence of chromatin marker dots which were seen emanating from specific chromosomes. This was not only clearly identifiable by variously stained metaphases but even SCE studies (sister chromatid exchanges) have had exactly localised the place and modes of origin of chromatin material (Figure 1). The released material could be either linear or a dot and even chromosomes have been seen detaching a marker dot still attached with a fibril (see arrows and lines in Figure 1; [12]. Now that small chromatin structures, described by a large number of workers as small supernumerary chromosomes (SMCs), which originate from any chromosome within the cell are associated with some or the other pathological condition has been well established. Cytogeneticists from various laboratories [17-22] have established that appearance of SMCs is associated with the developmental errors leading to some or the other pathological condition or a syndrome (Table 1). Observations listed in the Table 1 perfectly match with our earlier published observations but offer more scientific importance on account of use of most modern investigational methodologies.

Our earlier observations [5,7] regarding these chromatin structures to which we had named as marker dots (MDs) and present discussions have been presented in Figure 2 and

Table 2 and also briefly mentioned hereunder:

Table 2 This table is based on computation of clear metaphases indicating the location of CG (Chromatin bodies or Marker Dots positively stainable with both C and G banding

This table is based on computation of clear metaphases indicating the location of CG (Chromatin bodies or Marker Dots positively stainable  with both C and G banding

(1) This becomes imperative to reemphasize that these chromatin dots seen emanating from chromosomes are decidedly early indicators of chromosomal mutagenesis. We have confirmed by G, and C banding as well as by Feulgen’s staining and fluorescence procedures that these are chromatin bodies found in patients of cancers (bone, breast, lung and colon in particular) and sometimes in a few of their family members (2). Family members prone to cancer were found to exhibit marker dots and developed clinical signs of cancer after 03 to 05 years after our report. Marker dots measuring 2-to-3 micron emanate from different chromosome in several metaphases in preparations from cancer patients obviously, it appears that the molecular attenuation of chromatin structures movable from chromosomes is related with triggering neoplastic transformations (3). These dots appear in those metaphases which exhibit translocations and acrocentric associations, which are precursors to installation of chromosomal mutagenesis as established since the time of Boveri. Marker dots can be reliable early indicators of precancerous patients; may help in early detection. We have evidences for this pronouncement. In the background we have a credited discovery of marker dots particularly in those families which have had a cancer patient and identify a possible susceptible person. Out of our 17 such cases adjudged, 13 had started showing signs of malignancy within 3-5 years of yearly follow up study. Our prognostic approaches were admired by surgeons during their treatments of various patients.

DISCUSSION

Chromosome involvement in malignancy has been known since the time of Boveri and hundreds of papers have been published in accordance with this concept that molecular mechanism of malignancy leading to clinical cancer is always associated with chromosomal aberrations including polyploidy as well as new small chromatin structures called as double minutes [24-26]. Double minutes, though are two small dots giving a small dumbel shape and can be well examined under light microscope, but molecularly are overloaded with oncogenes. Marker dots or SMCs as most other workers designate, are additional chromatin structures whose origin is from the chromosome(s) within the cell and these are affiliated to a large number of pathological conditions and developmental errors. There are strong reasons to suggest that neither Marker Dots nor SMCs should be referred as “chromosomes”. Chromosomes should be defined as “compound unit of inheritance loaded with sequences of nucleic acids following intracellular molecular events of transmission and cell division”. Since neither SMCs nor marker dots, though, both have been shown to be produced by any chromosome within a cell, have definite centromere, we can best designate them as marker dots. Both must have a fraction of heterochromatin with which these can sometimes attach to any chromosome and move to poles during anaphasic movements. Obviously, just like micro chromosomes in birds and reptiles these “expelled chromatin structures do possess some part of the heterochromatin which can facilitate retention in few (not all) cells. Both marker dots and also SMCs are not present in all cells.

CHROMOSOME SITE?

This is a moot question that from which part or specific locus does a Marker Dot or SMC arise?. [27] specified the origin from centromere all other workers have presented definitive evidences on the basis of most modern molecular genetic methods (including bandings, in situ hybridizations etc) that SMCs can arise from any (terminal or telomeric, interstitial or from any part of the chromosome). Goswami has also presented the origin of MDs (Marker Dots) from many parts including centromeric and telomeric regions and most remarkably in many cases the exact detaching perfectly stained fine thread or fibril has been shown (review, [13]. Almost all chromosomes in human genome can emanate the chromatin dot-structure. SMCs have been proved to be always associated with some or the other pathological disorder and or a developmental error (Table 1). With the help of very elegant studies by various workers [17,18,28] on genotype-tophenotype correlation was possible because the supernumerary marker chromosomes were fully characterized by array-based comparative genomic hybridization in a genome-wide analysis. The genetic significance of these marker dots or SMCs as these were called later (without mentioning about marker dots) have been known for quite some time [6-10,12-16,29].

CHROMOSOMAL MECHANISM

Chromosome-assay is one of the most reliable approaches in assessing genetic damages induced by any environmental agent. Our group followed the conventional study of mutational damages both by SCE (sister chromatid exchanges) as well as by scoring chromosomal aberrations. Based on publications [5,8] and thereafter we have opined that there are individuals in Bhopal (to whom we could reinvestigate at least three times; a few of them were investigated in early 1994 as routine practice of cytogenetics unit of the department of Genetics, Bhopal University) who still show the induced aberrations particularly rare kinds of translocations. As shown in Figure 1, which is a metaphase cell showing increased mutagenesis by sister chromatid exchanges (SCE) many parts of several chromosomes show release chromatin fragment and dots expelled from respective or probably nearby chromatid (see Figure 1. for details). What we have categorically mentioned [12] is that “chromatin attenuation” at any or more loci is triggered by some molecular mechanism (may be an epigenetic phenomenon ?). Scoring such aberrant cells on large scale and statistically counting metaphases we have found that translocations are in greater proportion in those cells where MDs are observed but all aberrations do offer possibility involving several chromosomes (See Tables 1, 2 and Figure 2). Acrocentric associations and premature centromeric divisions are also highly pronounced which are apparently not normal events. But these aberrations always do not involve the same “parental chromosome” generating a SMC or marker dot.

Whatever is the molecular mechanism responsible for the generation or expulsion of chromatin from a chromosome (“marker dots” or small marker chromosomes) one physically visible process is the attenuation of a part of chromatin within a chromosome. These attenuated chromatin dots are being randomly expelled from specific chromosomes [5,8,12,13] (Figure 1). Results of genomic DNA studies and matching with some oncogenic expressions are still unpublished needing repetitions. But this appears logical that the type of abnormal developmental feature or a pathological condition or appearance of a syndrome should be related with the activated DNA sequences on the basis of the chromatin make up and the part from where and which chromosome this extra chromatin structure has been derived. Both, SMCs as well as Marker dots are found in some seemingly normal persons also [5]. Our follow-up studies of the same persons have indicated that in due course these could be early warnings [6,12-15] for a pathological anomaly including recurrent abortions and or malignancy. In other words, presence of marker dots can help in genetic counselling as well.

ACKNOWLEDGEMENTS

I am grateful to galaxy of my students who did work with me on human chromosomes during 1984-2002 in the department of Genetics, Barkatullah University Bhopal, India. I have frequently used slides and photographs for publications and I must confess, as usual, that I owe a great admiration for their very hard collaboration and sincere efforts.

REFERENCES

1. Cox D, Yuncken C, Springs A. Minute chromatin bodies in malignant tumours of childhood. Lancet. 1965; 2: 55-58.

2. Lubs HA, Salmon JH, Flanigam S. Studies of a glial tumour with multiple minute chromosomes. Cancer. 1966; 19: 591.

3. Dharker RS, Chaurasia BD, Goswami HK. Comparative Cytology of Human Brain Tumours. Mamm. Chrom. 1973a; 14: 100-107.

4. Dharker RS, Chaurasia BD, Goswami HK. Hypoploidy in Brain Tumours. Acta Biol Acad Sci Hung. 1973b; 24: 233-235.

5. Goswami HK. Cytogenetic effects of Methyl Isocyanate exposure in Bhopal. Human Genetics. 1986.

6. Goswami HK. Marker dot is indicator of Chromosomal Mutagenesis. In: Haldane & Evolution. Bionature. 1993; 13: 325-333.

7. Goswami HK, Chandorkar MS, Bhattacharya K, Vaidyanath G, Parmar D, Sengupta S, et al. Search for Chromosomal variations among gas exposed persons in Bhopal. Human Genetics. 1990; 84: 172-176.

8. Goswami HK, Rangnekar GV, Varshney S, Gandhi P, Jain B, Joshi A. Crossed Renal Ectopia with pelvic lipomatosis: A new Syndrome involving Chromosome 1. Human Genetics. 1992; 89: 666-670.

9. Goswami HK, Shrivastava N, Gopal SK, Sharma S, Chandorkar MS, Lee IH, et al. Unusual chromosomal features in a child with gradual disappearance of Right Ulna (mono ostolic osteolysis). J Genet Med. 1997; 1: 11-16.

10. Goswami HK, Rangnekar AG, Sharma S, Varshney S, Lee IH, Chang SI. Hemihypertrophy with hypomelanosis of Ito: A new syndrome combination. J Genet Med. 1998; 2: 1-5.

11. Goswami HK, Rangnekar A, Sikarwar LS. Population Cytogenetics of Abortions and Vanishing Twin Indian Journal of Fundamental and Applied Life Sciences. 2011; 1: 36-42.

12. Goswami HK, Chang SI. Marker dots are expelled by attenuation in heterochromatin of a chromatid. Bionature. 2001; 21: 41–48.

13. Goswami HK. Cells with Chromosomal Aberrations Trigger Neoplastic Transformations in Humans. Twin Research and Human Genetics. 2016; 19: 77–79.

14. Goswami HK. Is tendency to recurrently abort, a rejected malignant activity in developing embryonic tissue ? Obstet Gynecol Rep. 2017 a; 1: 2-3.

15. Goswami HK. Gross Chromosomal Aberrations Are Early Alarms for Malignancy: A Re-Emphasis. Hereditary Genet. 2017 b; 6: 187.

16. Goswami HK. Ceaseless Replication and Random Distribution of DNA Sequences during Early Phases of Evolution is Responsible for Unrelated-Homologies. J. Genet Genome. 2018; 2: 2-12.

17. Dalpra L, Giardino D, Finelli P, Corti C, Valtotra C, Guerneri S, et al. Cytogenetic and molecular evaluation of 241 small supernumerary marker chromosomes: Cooperative study of 19 Italian laboratories. J Genet Med. 2005: 7: 620–625.

18. Pietrzak J, Mrasek K, Obersztyn E, Stankiewicz P, Kosyakova N, Weise A, et al. Molecular cytogenetic characterization of eight small supernumerary marker chromosomes originating from chromosomes 2, 4, 8,18, and 21 in three patients. Journal of Applied Genetics. 2007; 48; 167–175.

19. Bae MH, Yoo HW, Lee JO, Maria Hong M, SeoEJ. Molecular Cytogenetic Characterization of Supernumerary Marker Chromosomes by Chromosomal Microarray. J Genet Med. 2011; 8: 119-124.

20. Bing Huang, Phyllis Pearle, Katherine A. Rauen, Philip D, Cotter. Supernumerary marker chromosomes derived from chromosome 6: Cytogenetic, molecular cytogenetic, and array CGH characterization. 2012.

21. Chen CP, Ming C, Chern SR, Chang SP, Chen SW, Lai ST, et al. Prenatal diagnosis and molecular cytogenetic characterization of mosaicism for a small supernumerary marker chromosome derived from chromosome 21. Taiwanes J Obstetrics Gynecology. 2017; 56: 566- 568.

22. Kurtas NE, Xumerle L, Leonardelli L, Delledonne M, Brusco A, Chrzanowska K, et al. Small supernumerary marker chromosomes: A legacy of trisomy rescue? Human Mutation. 2018.

23. An Na, Yang Y, Xi Q, Yue F, Liu R, Li S, Wang R. Molecular Characterization of Mosaicism for a Small Supernumerary Marker Chromosome Derived from Chromosome Y in an Infertile Male with Apparently Normal Phenotype: A Case Report and Literature Review. BioMed Research International. 2019.

24. Levan A, Levan G. Have double minutes functioning centromeres? Hereditas. 1978; 88: 81-92.

25. Croce CM, Klein G. Chromosome transloctions and Human cancer. Scientific American. 1990; 44-51.

26. Yihui Fan, Renfang Mao, Hongpei Lv, Jie Xu, Lei Yan, Yanhong Liu, et al. Frequency of double minute chromosomes and combined cytogenetic abnormalities and their characteristics. Journal of Applied Genetics. 2011; 52: 53–59.

27. Jansen LET, Black BE, Foltz DR, Cleveland DW. Propagation of centromeric chromatin requires exit from mitosis. The Journal of Cell Biology. 2007; 176: 795-805.

28. Reddy KS, Swaroop A, Meck J, Tiller G, Abboy S, Bass H. Systematic analysis of small supernumerary marker chromosomes using array cGH exposes unexpected complexity. Genet Med. 2013: 15: 3–13.

29. Goswami HK. Genetic significance of marker dots. In, Perspectives in Cytology & Genetics; Edts G K Manna & S C Roy, AICC, Kalyani, India. 2001; 10: 265-269.

Goswami HK (2020) Many Developmental Errors and or Pathological Conditions May Be Associated with Marker Dots /Small Supernumerary Chromosomes. J Family Med Community Health 7(1): 1169.

Received : 17 Dec 2020
Accepted : 06 Jan 2020
Published : 08 Jan 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X